Skip to main content

cytarabine; daunorubicin

Generic: CYTARABINE; DAUNORUBICIN·Brand: VYXEOS

cytarabine; daunorubicin: 3 clinical trials tracked.

cytarabine; daunorubicin evidence translation

What we can confirm

3 tracked trials

No verified listed developer

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about cytarabine; daunorubicin, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 1 study sponsors

Related indications

Acute Myeloid Leukemia
Clinical Trials (3)

A Phase 1/1b Dose Escalation and Expansion of CPX-351 in Combination With Gemtuzumab Ozogamicin in Newly Diagnosed Acute Myeloid Leukemia

NCT05558124·Phase 1
Recruiting

Primary endpoint: Maximum Tolerated Dose (MTD)

Interventionalopen18 targetStarted 2023-02Completion 2027-041 site · United StatesH. Lee Moffitt Cancer Center and Research Institute

A Phase 1 Study of Vyxeos Plus Gilteritinib in Relapsed or Refractory, FLT3-Mutated Acute Myeloid Leukemia

NCT05024552·Phase 1·JAZZ
Recruiting

Primary endpoint: Maximum Tolerated Dose (MTD)

Interventionalopen22 targetStarted 2022-02Completion 2027-031 site · United StatesH. Lee Moffitt Cancer Center and Research Institute

An International Randomised Clinical Trial of Therapeutic Interventions to Assess the Effects on Outcome in Adults With Acute Myeloid Leukaemia and High Risk Myelodysplasia Undergoing Allogeneic Stem Cell Transplantation.

NCT04217278·Phase 2/Phase 3
Active, not recruiting

Primary endpoint: Overall survival (all randomisations)

InterventionalRandomizedopen333 targetStarted 2020-01Completion 2026-0514 sites · United KingdomUniversity of Birmingham